Cargando…

The influence of tamoxifen on normal mouse mammary gland homeostasis

INTRODUCTION: Lineage tracing using inducible genetic labeling has emerged to be a powerful method for interrogating the developmental fate of cells in intact tissues. A common induction mechanism is the use of tamoxifen-dependent Cre recombinase (CreER and CreER(T2)), but the effects of tamoxifen a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shehata, Mona, van Amerongen, Renée, Zeeman, Amber L, Giraddi, Rajshekhar R, Stingl, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303226/
https://www.ncbi.nlm.nih.gov/pubmed/25056669
http://dx.doi.org/10.1186/s13058-014-0411-0
_version_ 1782353911304159232
author Shehata, Mona
van Amerongen, Renée
Zeeman, Amber L
Giraddi, Rajshekhar R
Stingl, John
author_facet Shehata, Mona
van Amerongen, Renée
Zeeman, Amber L
Giraddi, Rajshekhar R
Stingl, John
author_sort Shehata, Mona
collection PubMed
description INTRODUCTION: Lineage tracing using inducible genetic labeling has emerged to be a powerful method for interrogating the developmental fate of cells in intact tissues. A common induction mechanism is the use of tamoxifen-dependent Cre recombinase (CreER and CreER(T2)), but the effects of tamoxifen at doses normally used in lineage-tracing studies on normal adult mammary gland homeostasis are not known. METHODS: We used flow cytometry and immunostaining of intact glands to determine whether varying doses of tamoxifen skew the distribution and the apoptosis and proliferation status of different types of mammary epithelial cells in vivo. We also examined how tamoxifen influences the number of progenitor and mammary repopulating units (MRUs). RESULTS: Our results indicate that ≥5 mg/25 g body weight of tamoxifen induces a transient increase in cell proliferation and in the number of basal cells in the adult mammary epithelium up to 7 days after tamoxifen administration. However, in the medium term (3 weeks), all doses of tamoxifen ≥1 mg/25 g body weight result in a decrease in the number of basal and EpCAM(+)CD49b(−) luminal cells and a decrease in progenitor cell function. Tamoxifen at doses ≥5 mg/25 g body weight induced a transient increase in caspase-3-mediated apoptotic cell death within the mammary epithelium. However, mammary epithelial cell numbers in all subpopulations were restored to their original levels by 8 weeks. No long-lasting effects of tamoxifen on MRU numbers or on pubertal ductal development were observed. CONCLUSION: Tamoxifen can skew the distribution of mammary cell types in a dose-dependent manner, and thus caution must be taken when interpreting lineage-tracing studies using high doses of tamoxifen, particularly when short-duration analyses of a quantitative nature are being performed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-014-0411-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4303226
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43032262015-01-23 The influence of tamoxifen on normal mouse mammary gland homeostasis Shehata, Mona van Amerongen, Renée Zeeman, Amber L Giraddi, Rajshekhar R Stingl, John Breast Cancer Res Research Article INTRODUCTION: Lineage tracing using inducible genetic labeling has emerged to be a powerful method for interrogating the developmental fate of cells in intact tissues. A common induction mechanism is the use of tamoxifen-dependent Cre recombinase (CreER and CreER(T2)), but the effects of tamoxifen at doses normally used in lineage-tracing studies on normal adult mammary gland homeostasis are not known. METHODS: We used flow cytometry and immunostaining of intact glands to determine whether varying doses of tamoxifen skew the distribution and the apoptosis and proliferation status of different types of mammary epithelial cells in vivo. We also examined how tamoxifen influences the number of progenitor and mammary repopulating units (MRUs). RESULTS: Our results indicate that ≥5 mg/25 g body weight of tamoxifen induces a transient increase in cell proliferation and in the number of basal cells in the adult mammary epithelium up to 7 days after tamoxifen administration. However, in the medium term (3 weeks), all doses of tamoxifen ≥1 mg/25 g body weight result in a decrease in the number of basal and EpCAM(+)CD49b(−) luminal cells and a decrease in progenitor cell function. Tamoxifen at doses ≥5 mg/25 g body weight induced a transient increase in caspase-3-mediated apoptotic cell death within the mammary epithelium. However, mammary epithelial cell numbers in all subpopulations were restored to their original levels by 8 weeks. No long-lasting effects of tamoxifen on MRU numbers or on pubertal ductal development were observed. CONCLUSION: Tamoxifen can skew the distribution of mammary cell types in a dose-dependent manner, and thus caution must be taken when interpreting lineage-tracing studies using high doses of tamoxifen, particularly when short-duration analyses of a quantitative nature are being performed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-014-0411-0) contains supplementary material, which is available to authorized users. BioMed Central 2014-07-24 2014 /pmc/articles/PMC4303226/ /pubmed/25056669 http://dx.doi.org/10.1186/s13058-014-0411-0 Text en © Shehata et al.; licensee BioMed Central 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Shehata, Mona
van Amerongen, Renée
Zeeman, Amber L
Giraddi, Rajshekhar R
Stingl, John
The influence of tamoxifen on normal mouse mammary gland homeostasis
title The influence of tamoxifen on normal mouse mammary gland homeostasis
title_full The influence of tamoxifen on normal mouse mammary gland homeostasis
title_fullStr The influence of tamoxifen on normal mouse mammary gland homeostasis
title_full_unstemmed The influence of tamoxifen on normal mouse mammary gland homeostasis
title_short The influence of tamoxifen on normal mouse mammary gland homeostasis
title_sort influence of tamoxifen on normal mouse mammary gland homeostasis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303226/
https://www.ncbi.nlm.nih.gov/pubmed/25056669
http://dx.doi.org/10.1186/s13058-014-0411-0
work_keys_str_mv AT shehatamona theinfluenceoftamoxifenonnormalmousemammaryglandhomeostasis
AT vanamerongenrenee theinfluenceoftamoxifenonnormalmousemammaryglandhomeostasis
AT zeemanamberl theinfluenceoftamoxifenonnormalmousemammaryglandhomeostasis
AT giraddirajshekharr theinfluenceoftamoxifenonnormalmousemammaryglandhomeostasis
AT stingljohn theinfluenceoftamoxifenonnormalmousemammaryglandhomeostasis
AT shehatamona influenceoftamoxifenonnormalmousemammaryglandhomeostasis
AT vanamerongenrenee influenceoftamoxifenonnormalmousemammaryglandhomeostasis
AT zeemanamberl influenceoftamoxifenonnormalmousemammaryglandhomeostasis
AT giraddirajshekharr influenceoftamoxifenonnormalmousemammaryglandhomeostasis
AT stingljohn influenceoftamoxifenonnormalmousemammaryglandhomeostasis